WELL Health Technologies (WELL) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
4 May, 2026Opening remarks and agenda
Meeting called to order by the chairman, with appointments for secretary, scrutineer, moderator, and legal formalities established.
Rules for virtual meeting conduct and electronic voting procedures were outlined for orderly proceedings.
The agenda was set according to the Management Information Circular dated May 3, 2024.
Corporate governance
Quorum was confirmed, and proof of proper notice and mailing was filed and annexed to the minutes.
The number of directors was set at six, with all nominated directors confirming their willingness to serve.
Election of directors proceeded with no other nominations or questions from shareholders.
Board and executive committee updates
Six directors were nominated and elected to serve until the next annual meeting or until successors are appointed.
Latest events from WELL Health Technologies
- Q2-2026 revenue hit CAD 400.4M; 2026 guidance raised on strong growth and acquisitions.WELL
Q2 2026 - Record Q1-2026 revenue and EBITDA growth driven by Canadian clinics and tech expansion.WELL
Q1 2026 - Record revenue and EBITDA growth, robust M&A pipeline, and strong 2026 outlook.WELL
Q4 2025 - Record Q3 revenue and EBITDA, strong Canadian growth, and robust M&A pipeline for 2025.WELL
Q3 2025 - Record Q2 revenue, EBITDA, and raised guidance driven by growth, M&A, and HEALWELL AI.WELL
Q2 2025 - Record Q3 revenue, margin expansion, and raised 2024 guidance driven by strong organic growth.WELL
Q3 2024 - Record Q2 revenue, raised guidance, and AI-driven strategy fuel strong growth and efficiency.WELL
Q2 2024 - Q1 2025 saw 32% revenue growth, record EBITDA, Canadian focus, and U.S. divestments.WELL
Q1 2025 - Record revenue, 75% net income growth, and strong 2025 outlook despite deferred revenue.WELL
Q4 2024